Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck

Condition:   Squamous Cell Carcinoma of the Head and Neck
Interventions:   Drug: Pembrolizumab;   Other: Placebo
Sponsors:   Ezra Cohen;   Merck Sharp & Dohme Corp.
Not yet recruiting - verified May 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1Oi3fza
via IFTTT